Absci
Absci uses generative AI and an integrated drug creation platform to design and optimize biologic drugs, including antibodies, for pharmaceutical companies and patients. Its technology combines AI-driven de novo design, lead optimization, and wet lab validation to create therapeutics against difficult-to-drug targets, aiming to accelerate the development of better biologics for challenging diseases.
Facts
- HQ
- Vancouver, Wash.
- Sectors
- Biotechnology Research
- Founded
- 2011
- Employees
- 159
- Stage
- Public
- Members see funding amounts. .
Is this your organization? Claim it
Washougal-based Resect AI Raises $25 Million as Southwest Washington Startups Attract More Venture Capital
Resect AI in Washougal has secured $25 million in venture capital as part of growing venture interest in Southwest Washington startups, joining a regional trend of local firms attracting major funding despite limited institutional VC presence. Angel investors and emerging local funds, along with connections to Portland and Seattle firms, are helping startups like Digs and others access capital, mentorship and recruiting support.
Former Salesforce/Tableau EVP Teri Hatfield named CRO at Iterable; Gates Foundation lawyer Ken Miller joins Arnold & Porter; AIM and Gravitics add C-suite hires
Teri Hatfield left Salesforce/Tableau to become chief revenue officer at Iterable; Gates Foundation legal director Ken Miller joined Arnold & Porter as partner; and Seattle startups AIM and Gravitics appointed new C‑suite executives including AIM's CMO Ben Reed.
Talus Bio names Chris Joyce, MBA as VP of Business Development to drive pharma deals and advance TF therapeutics
Talus Bio hired Chris Joyce, MBA as VP of Business Development to accelerate pharma partnerships and advance its transcription factor therapeutics, including two programs targeting TBXT for non-small cell lung cancer and NONO-related androgen receptor splicing in castration-resistant prostate cancer.
See all 31 stories, episodes and videos about Absci.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 5-
Sean McClain Founder, CEO & Director
-
Sean McClain CEO and Founder
-
Sean McClain Founder and CEO